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Antibacterial activity, as detected in the bioautographic and microplate assays against Staphylococcus aureus, was shown for thirteen
homoisoflavanones isolated from six Hyacinthaceae species. Four of these homoisoflavanones were isolated from Eucomis comosa, one from
Eucomis schijffii, one from Albuca fastigiata, one from Drimia delagoensis, five from Drimiopsis maculata and one from Drimiopsis burkei.
Extracts from most of these plants are employed as traditional medicines in South Africa. Biological screening was followed by a computer-based
quantitative structure–activity relationship (QSAR) study. Stepwise multiple linear regression analysis of the data yielded a statistically significant
two-component model (R2=0.81, pb0.003), depicting logP and electron potential at O-1 as effective descriptors of antimicrobial activity against
S. aureus. The derived model provides valuable parameter guidelines for those properties influencing the antibacterial activity of these
homoisoflavanones.
© 2007 SAAB. Published by Elsevier B.V. All rights reserved.Keywords: Antibacterial activity; Homoisoflavanones; Hyacinthaceae; Physicochemical descriptors; Quantitative structure–activity relationships1. Introduction
The development of antimicrobial agents for clinical use has
brought unquestionable benefit to individuals and society.
Infectious diseases that were formerly often fatal became curable
(Lerner, 1998). However, mankind is now confronted with new
and re-emerging infections for which no effective treatments are
available (Cragg et al., 1997). In contrast to other types of
medication, antibiotics ultimately lose their effectiveness as they
are used over time and resistant strains of bacteria develop
(Lerner, 1998). One example is that of the Gram-positive,
methicillin-resistant Staphylococcus aureus. Incidence figures in
some hospitals have shown that more than 40% of S. aureus⁎ Corresponding author. School of Pharmacy and Pharmacology, Westville
Campus, University of KwaZulu-Natal, Private Bag X54001, Durban 4000,
South Africa.
E-mail address: karent@ukzn.ac.za (K. Du Toit).
0254-6299/$ - see front matter © 2007 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2007.01.002strains are now resistant tomethicillin (Lesse, 1995). There is thus
an urgent need to identify novel, active chemotypes as leads for
drug development (Cragg et al., 1997). Natural products could
play a crucial role in meeting this demand (Cragg and Newman,
2001). Of the drugs approved between 1983 and 1994 by either
the United States Food and Drug Administration (FDA) or com-
parable entities in other countries, drugs of natural origin pre-
dominated (78%) in the area of antibacterials (Cragg et al., 1997).
The presence of antibacterial activity in plants is important
from an ecological as well as pharmacological viewpoint (Cox
and Balick, 1994). Hyacinthaceous plants have been employed
in Xhosa and Zulu remedies for many years. The remedies are
used for purposes ranging from the treatment of rheumatic fever
and hangovers to syphilis (Pohl et al., 2000). Extracts from
Drimia delagoensis are incorporated in a protective cream
(Hutchings et al., 1996) and are also used to protect animal skins
from dogs (Watt and Breyer-Brandwijk, 1962) whilst Dri-
miopsis maculata is frequently used in enema preparations forts reserved.
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1996). The bulbs of the much sought-after Eucomis species are
used in Xhosa, Tswana, Zulu and Sotho medicine in decoctions
prepared from shaved bulbs and roots boiled in water or milk.
These decoctions are then used in infusions for the treatment of
pain and fever (Watt and Breyer-Brandwijk, 1962).
A large number of homoisoflavanones have been isola-
ted from several hyacinthaceous genera including Eucomis
L'Hér., Merwilla Speta, Ledebouria Roth, Veltheimia Gled. and
Drimiopsis Lindl. and Paxton (Pohl et al., 2000). Homoiso-
flavanones belong to a small homogeneous group of naturally
occurring oxygen heterocycles which, within the Hyacinthaceae,
are largely but not exclusively restricted to the subfamily Hyacin-
thoideae. The few reports on the biological activity of homoisofla-
vanones describe anti-inflammatory, antibacterial, antihistaminic,
antimutagenic and angioprotective properties, and potent phos-
phodiesterase inhibition (Della Loggia et al., 1989; Amschler et al.,
1996; Heller and Tamm, 1981).
The aim of this study was to determine the antibacterial
activity of the isolated homoisoflavanones against S. aureus and
also to develop a set of physicochemical parameters that would
describe antibacterial activity for these and future compounds.Fig. 1. Structures of compounds tested for antibac2. Experimental
2.1. Test compounds
The structures of the homoisoflavanones are given in Fig. 1.
The plant species from which these compounds were isolated as
well as the references of publications describing the isolation
and confirming the identity of the compounds isolated are listed
in Table 1. The structures and purity of all compounds isolated
were confirmed using NMR, MS and IR techniques and the
physical data was compared with that in the literature.
2.2. Antibacterial assays
The test compounds were screened against S. aureus (ATCC
12600) using the bioautographic and microplate assays (Eloff,
1998).
Test compounds were spotted on thin layer chromatography
(TLC) plates (Merck, Kieselgel 60 F254). The plates were then
developed in ethyl acetate/hexane (4:1) and left to dry over-
night. An overnight culture of S. aureus was sprayed onto the
TLC plate and incubated at 37 °C in an oven at 100% humidityterial activity against Staphylococcus aureus.
Table 1
Comparison of minimum inhibitory concentration and bacteriostatic concentration
(where applicable) values of homoisoflavanones tested against S. aureus with the
microplate assay
Compound number Reference Plant source MIC
(mM)
BC
(mM)
1 Koorbanally et al.
(2006a)
E.comosa (Houtt.)
Wehrh.
0.52
2 Koorbanally et al.
(2006a)
E.comosa (Houtt.)
Wehrh.
0.24
3 Koorbanally et al.
(2006b)
D.maculata Lindl. ⁎
4 Koorbanally et al.
(2006b)
D.burkei Baker ⁎
5 Koorbanally et al.
(2005a)
D.delagoensis
(Baker) Jessop
1.97
6 Koorbanally et al.
(2006b)
D.maculata Lindl. 3.95
7 Koorbanally et al.
(2006b)
D.maculata Lindl 0.47
8 Koorbanally et al.
(2006a)
E.comosa (Houtt.)
Wehrh.
4.15 2.07
9 Koorbanally et al.
(2006a)
E.comosa (Houtt.)
Wehrh.
0.98
10 Koorbanally et al.
(2005b)
A.fastigiata Dryand. ⁎
11 Koorbanally et al.
(2001)
D.maculata Lindl. 3.95 1.97
12 Koorbanally et al.
(2001)
D.maculata Lindl. 7.60
13 Koorbanally et al.
(2006a)
E. schijffii Reyneke 0.50
Neomycin 0.0025
⁎Compound showed antibacterial activity in the microplate assay but was not
available for further testing.
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p-iodonitrotetrazolium violet (INT) (Sigma). Bacteria reduce the
tetrazolium salt through dehydrogenase activity and produce an
intensely coloured formazan (Eloff, 1998). Inhibition of growth is
indicated by clear zones against a dark pink background.
Compounds that showed antibacterial activity with the
bioautographic method, were further tested to establish their
MIC values using the initial concentration of 10 mg/ml in
ethanol or DMSO. Sterile water (100 μl) was added to each well
of the microplates. For each dissolved compound a two-foldTable 2
Summary of computational descriptors employing the Spartan Pro® program
Comp MIC (mM) SV SA SE
1 0.52 321.46 329.05 42.031
2 0.24 331.42 337.53 49.029
5 1.975 338.39 346.04 30.690
6 3.95 338.16 344.93 42.450
7 0.47 359.62 367.50 57.020
8 4.15 329.21 337.70 35.520
9 0.98 338.17 344.93 39.233
11 3.95 327.12 332.57 52.600
12 7.60 347.79 352.83 64.400
13 0.50 316.71 321.41 44.580
SV=volume of a space-filling model (Å3), SA=surface area of a space-filling model (
moment (debyes), ES=aqueous phase energy (kcal/mol), VEL=vibrational enthalphserial dilution was made down the microplate starting at a
concentration of 5.0 mg/ml. An overnight bacterial culture was
diluted (1:100) in Mueller–Hinton (MH) broth and 100 μl
added to each well. This gives a further dilution to 2.5 mg/ml.
The following day 40 μl of 0.2 mg/ml INT was added to each
well and the plates incubated at 37 °C for 30 min. With INT the
bacterial suspension turned red where bacterial growth was not
inhibited. Where bacterial growth was inhibited, the suspension
in the well remained clear. Bacteriostatic activity caused the
wells to become a faint pinkish brown colour. Neomycin
(50 μg/ml) was used as a positive control and solvent and
bacteria free wells were used as negative controls. Experiments
were repeated twice and the results of the antibacterial activities
of the test compounds are summarized in Table 1.
2.3. Physicochemical characterization
Modeling and structural optimization were accomplished
using PC Spartan Pro® 1.0 modeling software. MM+ and AM1
minimization models were used for molecular and electronic
calculations. Ground state energies were optimized using
MMFF94 (Merck Molecular Force Field) calculations. Strain
energy (SE) was determined from molecular mechanics
calculations and heat of formation (EF) from semi-empirical
calculations.
PC Spartan Pro® 1.0, was further used to calculate the
following parameters from the energy minimized structures:
volume of a space-filling model (SV), surface area (SA),
aqueous phase energy (ES), dipole moment (DP), vibrational
enthalpy (VEL), and vibrational entropy (TE) (Table 2).
Descriptors measuring electron potential at atomic level were
also calculated using Spartan Pro® and are summarized in
Table 3. Advanced Chemistry Development's ACD program
was used to calculate parameters for molar refractivity (MR),
parachor (P), density (D), refractive index (RI), surface tension
(ST), polarizability (POL) and logP (Table 4). The Insight II
program was used to calculate parameters for Van der Waals
interaction energy (VE), Coulombic interaction energy (CE)
and total non-bonded interaction energy (NIE) (Table 5).
Microsoft Excell® spreadsheets were generated containing
biological activity values as well as physicochemical property
values for the different compounds. The sets of data were ofEF DP ES VEL TE
−129.009 4.695 −13.354 191.155 61.656
−170.755 4.170 −14.321 194.730 66.123
−199.494 3.721 −15.554 209.547 69.950
−194.216 4.949 −14.896 209.379 71.084
−187.646 0.960 −12.612 228.349 76.782
−148.494 1.005 −16.351 205.540 65.131
−197.384 3.747 −14.052 209.447 68.748
−144.490 2.480 −17.000 194.641 62.952
−139.098 1.380 −13.520 213.689 68.908
−124.439 3.380 −16.820 180.704 54.808
Å2), SE=strain energy (kcal/mol), EF=heat of formation (kcal/mol), DP=dipole
y (kcal/mol), TE=vibrational enthropy (cal/mol.K).
Table 3
Summary of computational descriptors measuring electron potential at atomic level utilizing the Spartan Pro® program
⁎⁎
Comp MIC (mM) C8 C5 C8a C7 C6 C4a O1 C2 C3 C4
1 0.52 −0.590 0.699 0.582 0.598 −0.622 −0.775 −0.408 0.212 −0.354 0.798
2 0.24 −0.198 0.670 0.426 0.539 −0.610 −0.738 −0.303 0.111 −0.309 0.793
5 1.97 −0.578 0.707 0.565 0.599 −0.626 −0.794 −0.408 0.198 −0.287 0.773
6 3.95 −0.470 0.570 0.478 0.386 −0.140 −0.760 −0.401 0.175 −0.288 0.820
7 0.47 −0.228 0.678 0.540 0.484 −0.584 −0.829 −0.360 0.156 −0.275 0.817
8 4.15 −0.467 0.489 0.504 0.481 −0.480 −0.610 −0.403 0.180 −0.233 −0.155
9 0.98 −0.240 0.737 0.458 0.601 −0.676 −0.820 −0.306 0.103 −0.249 0.800
11 3.95 −0.573 0.718 0.574 0.597 −0.626 −0.835 −0.409 0.189 −0.155 0.820
12 7.60 −0.600 0.644 0.635 0.576 −0.560 −0.819 −0.412 0.230 −0.331 0.854
13 0.50 −0.565 0.725 0.570 0.600 −0.629 −0.844 −0.402 0.182 −0.171 0.824
⁎⁎This structure does not represent any specific molecule. It is used to show which atom (if present) is represented in the table.
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increased the accuracy of the models. Individual correlation
trends between biological activity and physicochemical
descriptors of compounds were evaluated by means of linear
regression analysis as well as polynomial least square fit
procedures (the nature of the curve was assessed by the linear
correlation coefficient R2), using the Statistica® data analysis
software system. Models produced in this study were validated
by evaluating the residues for normality. The data was analyzed
for indications of high colinearity between property parameters
which would overly influence the calculation of the regression
function. In these cases only one member of each cluster
showing colinearity was used to increase independent variation
in physical properties.
3. Results and discussion
3.1. Antibacterial assay
Compounds that showed antibacterial activity in the
bioautographic method, were chosen, depending on availability,Table 4
Summary of computational descriptors employing the ACD® program
Comp MIC (mM) MR P RI ST D POL LogP
1 0.52 81.24 604.8 1.69 65.7 1.40 32.20 4.01
2 0.24 83.12 620.1 1.71 74.7 1.49 32.95 3.85
5 1.97 81.65 634.1 1.66 67.3 1.43 32.36 2.75
6 3.95 81.65 634.1 1.66 67.3 1.42 32.36 2.79
7 0.47 86.44 677.5 1.62 56.6 1.33 34.27 3.12
8 4.15 79.77 618.9 1.63 59.3 1.34 31.62 2.23
9 0.98 81.65 634.1 1.65 67.3 1.42 32.36 2.43
11 3.95 78.70 601.2 1.74 92.4 1.62 31.20 2.64
12 7.60 83.53 644.6 1.68 75.2 1.50 33.11 2.82
13 0.50 76.86 575.0 1.77 95.7 1.69 30.47 3.54
MR=molar refractivity (Å3), P=parachor (Å3), RI=refractive index, ST=sur-
face tension (dyn/cm), D=density (g/cm3), POL=polarizability (Å3), LogP=1-
octanol-water partition coefficient.for determination of Minimum Inhibitory Concentration (MIC)
and Bacteriostatic Concentration (BC) values.
Significant inhibitory activity against S. aureus was shown
by compounds 1, 2, 7 and 13 with MIC values of ≤0.52 mM.
The only compounds exhibiting bacteriostatic activity were
8 and 11. Although compounds 3, 4 and 10 also exhibited
antibacterial activity in the bioautographic assay, quantities
available were not sufficient for further testing.
Although little is known about the antimicrobial activity of
the specific Eucomis species from which the test compounds
were isolated, the ethnomedicinal usage of all Eucomis species
in terms of antimicrobial activity was broadly considered.
E. autumnalis (Mill.) Chitt. (Hutchings et al., 1996) and E. regia
(L.) L'Hér. (Watt and Breyer-Brandwijk, 1962) are used for
coughs and respiratory problems. Leaves of E. autumnalis
(syn. E. undalata Aiton) are sometimes used as a poultice on
suppurating sores and boils and the juice of the stems are used to
soothe sores and rashes (Roberts, 1990). Secondary infections
of S. aureus are associated with pneumonia, bronchitis and
suppurative infections like boils (Venter, 1997). The homoiso-
flavanones present in Eucomis species (Pohl et al., 2000) couldTable 5
Summary of computational descriptors employing the Insight II® program
Compound no MIC (mM) VE CE NIE
1 0.52 72.40 −4.31 68.09
2 0.24 71.10 −2.23 68.87
5 1.97 73.91 −14.29 59.61
6 3.95 74.21 −0.54 73.66
7 0.47 74.51 −5.41 69.09
8 4.15 71.32 −14.29 57.03
9 0.98 72.34 −9.41 62.93
11 3.95 73.04 −5.47 67.58
12 7.60 75.64 0.64 76.28
13 0.50 70.64 −3.09 67.55
VE=Van der Waals interaction energy (kcal/mol), CE=coulombic interaction
energy (kcal/mol), NIE=non-bonded interaction energy (kcal/mol).
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species against respiratory problems, as well as sores and boils.
Compound 7 isolated from D. maculata showed antimicro-
bial activity with a MIC value of 0.47 mM. Compounds 6, 11
and 12 from D. maculata also exhibited antimicrobial activity
and the activity of the compounds isolated from this plant
validates its popularity amongst traditional healers. D. macu-
lata, considered non-toxic (Hutchings et al., 1996), is rated
amongst the twenty-three most popular plants grown by Zulu
traditional healers at their homes (Mander, 1997).
3.2. QSAR models for compounds with antibacterial activity
Simple linear regression analysis revealed a statistically
significant correlation between antimicrobial activity and logP
(R2 =0.75, pb0.050). Stepwise multiple linear regression
analysis of all data (Tables 2–5), yielded a five-component
model (R2 =0.95, Adj.R2 =0.89, pb0.009, n=10, Eq. (1)),
depicting logP, Coulombic interaction energy (CE) and electron
potential at C-4a, C-2 and O-1 as effective descriptors of anti-
microbial activity (MIC).
−logMIC ¼ −2:45−4 : 90 C−2ð Þ þ 0 : 99 logPð Þ−0 : 07 CEð Þ
−6:36 C4að Þ þ 7:44 O−1ð Þ
ð1Þ
The ratio between the parameters in the above equation, and
the number of test compounds may however result in a
overfitting of data and a three-component model (R2=0.89,
pb0.002) was obtained by omitting the electron potential of C-2
and C-4a. Removing Coulombic interaction energy (CE) as well
gave a two-component model (R2 = 0.81, Adj.R2 =0.75,
pb0.003, Eq. (2)).
−logMIC ¼ 0:39þ 0:59 logPð Þ þ 6:05 O−1ð Þ ð2Þ
Predicted MIC values derived from this equation were
correlated against experimental MIC values and it was found
that Eq. (2) has a significant descriptive value (see Fig. 2).
From the equations above, the influence of logP is clear. The
significant role that logP plays in the antimicrobial activity ofFig. 2. Correlation between the predicted MIC values (from Eq. (2)) and that
obtained experimentally.homoisoflavanones suggests that the compounds have to cross a
biological membrane in order to interact with the intra-bacterial
active site to exhibit biological activity.
Although lipophilicity is very important for the partitioning
of compounds the hydrogen bond acceptor/donor properties of
compounds also influence the diffusion through membranes.
Roberts et al. (1996) found that the introduction of one
hydrogen-bonding group caused a dramatic reduction in
diffusion, second and third groups caused further reduction
(although non-linear), and additional groups had no effect.
Thus above a saturable number of H-bonding groups diffusion
of compounds seems to be constant (Roberts et al., 1996). Since
the homoisoflavanones and related compounds studied are
highly oxygenated with at least two hydroxyl groups attached,
most of them probably reached the saturation point in terms of
H-bonding.
The oxygen of the carbonyl group at position 4 forms an
intramolecular hydrogen bond with the proton of the hydroxyl
group at position 5 in most of the homoisoflavanones studied.
This intramolecular hydrogen bond decreases the possibility of
intermolecular hydrogen bonding with water and should
decrease water solubility (Malan et al., 2002). Inductive effects
due to electron-withdrawing groups (the oxygen atoms in the
case of homoisoflavanones) will also increase the logP value
when hydrogen-bonding groups are involved (Nogrady, 1988).
Resonance effects are also important as delocalization of
non-bonded electrons into aromatic systems will decrease their
availability for hydrogen bonding with water and increase the
logP value (Nogrady, 1988). The extra 3,9-double bond in the
3-benzylidene-4-chromanone-type homoisoflavanones, com-
pounds 1 (logP=4.01; MIC=0.52 mM) and 2 (logP=3.85;
MIC=0.24 mM), will increase the number of resonance
structures (Loudon, 1988) for delocalization of non-bonded
electrons, decreasing the availability of these electrons for
hydrogen bonding and increasing the logP value.
The inclusion of parameters like Coulombic interaction
energy (CE) that takes into account the interaction of charges
and electron potential at different carbon atoms (C-4a, C-2 and
O-1) describe electronic characteristics and give a strong
indication of the importance of these descriptors for antibacte-
rial activity. Though they may have an effect on the partitioning
of the compounds, a role in the actual activity (binding at the
active site) of the compounds cannot be ruled out.
The regression models for compounds with antimicrobial
activity indicated that the active compounds must be able to
penetrate cell membranes as logP played an important role in
the activity of these compounds. Lipophilic groups like
halogens substituted at non-sensitive positions will increase
the lipophilicity of these compounds (Wermuth, 1996). Fluorine
has the advantage of its small size and will pose less steric
effects (Wermuth, 1996). Thus, homoisoflavanones and related
compounds can be synthesized with chlorine or fluorine atoms
in non-sensitive positions to increase the logP value. Another
way of increasing the logP value would be to replace methoxy
groups with ethoxy groups (Wermuth, 1996). Electrostatic
interaction energy impacts on the binding abilities of these
compounds to the active site and care must be taken not to
241K. Du Toit et al. / South African Journal of Botany 73 (2007) 236–241replace important substituents that influence the electron
potential as expressed in the equations.
4. Conclusion
A statistically significant two-component model (R2 =0.81,
pb0.003), depicting logP and electron potential at O-1 as
effective descriptors of the activity of the studied homoiso-
flavanones against S. aureus, was obtained during this study. It
must be emphasized that the different parameters are influenced
by different factors and cannot be taken account of as single
parameters as this will be an oversimplification of the actual
state. The prediction capabilities of the model is also limited to
the compounds and physicochemical parameters studied.
However, the derived model provides valuable parameter
guidelines in terms of the properties influencing the activity
of the studied homoisoflavanones against S. aureus. Informa-
tion concerning the activity of these compounds can thus be
predicted with confidence after identification of structures
isolated/synthesized.
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